scholarly article | Q13442814 |
P50 | author | Yasmine Belkaid | Q28843432 |
David Hildeman | Q43178790 | ||
P2093 | author name string | Craig Gerard | |
Jörg Köhl | |||
Heiko Hawlisch | |||
Ralf Baelder | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | toll-like receptor | Q408004 |
P304 | page(s) | 415-426 | |
P577 | publication date | 2005-04-01 | |
P1433 | published in | Immunity | Q6005457 |
P1476 | title | C5a negatively regulates toll-like receptor 4-induced immune responses | |
P478 | volume | 22 |
Q56584390 | Q56584390 |
Q53293504 | A Critical Role for C5L2 in the Pathogenesis of Experimental Allergic Asthma |
Q52665602 | A Novel Role for C5a in B-1 Cell Homeostasis. |
Q34072341 | A protective role for C5a in the development of allergic asthma associated with altered levels of B7-H1 and B7-DC on plasmacytoid dendritic cells |
Q42740328 | A protective role of complement component 3 in T cell-mediated skin inflammation |
Q28748788 | A recombinant vaccine effectively induces c5a-specific neutralizing antibodies and prevents arthritis |
Q34416391 | A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma |
Q27438135 | Allergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyperresponsiveness in asthma-susceptible mice |
Q36411141 | An unexpected role for the anaphylatoxin C5a receptor in allergic sensitization |
Q41010630 | Anaphylatoxin C5a Regulates 6-Sulfo-LacNAc Dendritic Cell Function in Human through Crosstalk with Toll-Like Receptor-Induced CREB Signaling |
Q36718541 | Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis |
Q37038275 | Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes |
Q52565501 | Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV. |
Q37586359 | Breaking bad: manipulation of the host response by Porphyromonas gingivalis. |
Q35634924 | C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression |
Q43239293 | C57BL/6 and A/J Mice Have Different Inflammatory Response and Liver Lipid Profile in Experimental Alcoholic Liver Disease |
Q59097002 | C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a |
Q33868735 | C5a alters blood-brain barrier integrity in experimental lupus |
Q36107219 | C5a and toll-like receptor 4 crosstalk in retinal pigment epithelial cells |
Q36762146 | C5a inhibitor protects against ischemia/reperfusion injury in rat small intestine |
Q46163569 | C5a receptor signalling in dendritic cells controls the development of maladaptive Th2 and Th17 immunity in experimental allergic asthma |
Q34579613 | C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells |
Q39909707 | C5a regulates NKT and NK cell functions in sepsis. |
Q42233208 | C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression |
Q40318813 | C5aR contributes to the weak Th1 profile induced by an outbreak strain of Mycobacterium tuberculosis |
Q98177694 | C5aR1 Activation Drives Early IFN-γ Production to Control Experimental Toxoplasma gondii Infection |
Q45877606 | Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses |
Q40444704 | Complement Component 3 Regulates IFN-α Production by Plasmacytoid Dendritic Cells following TLR7 Activation by a Plant Virus-like Nanoparticle. |
Q28263460 | Complement System Part II: Role in Immunity |
Q33801802 | Complement activation by CpG in a human whole blood loop system: mechanisms and immunomodulatory effects |
Q35936168 | Complement activation product C5a is a selective suppressor of TLR4-induced, but not TLR3-induced, production of IL-27(p28) from macrophages |
Q34414162 | Complement anaphylatoxins as immune regulators in cancer |
Q26862615 | Complement and dysbiosis in periodontal disease |
Q37769810 | Complement and periodontitis. |
Q40952250 | Complement drives Th17 cell differentiation and triggers autoimmune arthritis. |
Q33623972 | Complement evasion by human pathogens |
Q44042948 | Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans |
Q60921703 | Complement factors C3a and C5a mimick a proinflammatory microenvironment and increase HBV IGRA sensitivity |
Q33432423 | Complement in disease: a defence system turning offensive |
Q36572985 | Complement in lung disease |
Q33769308 | Complement inhibition alleviates paraquat-induced acute lung injury |
Q37291621 | Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production |
Q41440265 | Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion |
Q48206428 | Complement takes its Toll: an inflammatory crosstalk between Toll-like receptors and the receptors for the complement anaphylatoxin C5a. |
Q42423633 | Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma |
Q29615484 | Complement: a key system for immune surveillance and homeostasis |
Q37486358 | Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host |
Q64118822 | Complementing the Cancer-Immunity Cycle |
Q33463280 | Cross-talk between TLR4 and FcgammaReceptorIII (CD16) pathways |
Q37959890 | Crosstalk between complement and toll-like receptors |
Q37691806 | Crosstalk pathways between Toll-like receptors and the complement system |
Q40161639 | Cyclosporin A and FK506 inhibit IL-12p40 production through the calmodulin/calmodulin-dependent protein kinase-activated phosphoinositide 3-kinase in lipopolysaccharide-stimulated human monocytic cells |
Q37106187 | Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production |
Q34369161 | Deception and manipulation: the arms of leishmania, a successful parasite |
Q30422603 | Determinants of food allergy |
Q39848642 | Differential capacity for complement receptor-mediated immune evasion by Porphyromonas gingivalis depending on the type of innate leukocyte |
Q35721145 | Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. |
Q24303123 | Drusen complement components C3a and C5a promote choroidal neovascularization |
Q85116395 | Editorial: Pattern recognition receptors and factor B: “complement”ary pathways converge |
Q35863812 | Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis |
Q37327503 | Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury |
Q24669712 | Function, structure and therapeutic potential of complement C5a receptors |
Q36903844 | Functional paradox in host-pathogen interaction dictates the fate of parasites |
Q37367089 | Functional roles for C5a receptors in sepsis |
Q37273299 | Harmful molecular mechanisms in sepsis |
Q92066140 | Histamine up-regulates oncostatin M expression in human M1 macrophages |
Q38229557 | IgG4-related disease and its pathogenesis-cross-talk between innate and acquired immunity |
Q36533402 | Immunobiology of Toll-like receptors: emerging trends |
Q45352011 | Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection |
Q30244210 | Innate and adaptive immunologic functions of complement in the host response to Listeria monocytogenes infection |
Q36022738 | Interactions between coagulation and complement--their role in inflammation |
Q49551272 | Leishmania donovani Inhibitor of Serine Peptidases 2 Mediated Inhibition of Lectin Pathway and Upregulation of C5aR Signaling Promote Parasite Survival inside Host |
Q51578236 | Microarray analysis of leukocytapheresis-induced changes in gene expression patterns of peripheral blood mononuclear cells in patients with ulcerative colitis. |
Q42911622 | Microbial hijacking of complement-toll-like receptor crosstalk |
Q30499616 | Microbial manipulation of receptor crosstalk in innate immunity |
Q41760986 | Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease |
Q64103359 | Modulation of Iberian Ribbed Newt Complement Component C3 by Stressors Similar to those Encountered during a Stay Onboard the International Space Station |
Q37309924 | Modulation of inflammation by interleukin-27. |
Q47868063 | Monitoring C5aR2 Expression Using a Floxed tdTomato-C5aR2 Knock-In Mouse. |
Q38991040 | More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation |
Q34149280 | Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation |
Q35609638 | MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway |
Q94374182 | NEGATIVE REGULATORY EFFECTS OF PHOSPHATIDYLINOSITOL3-KINASE PATHWAY ON PHAGOCYTOSIS AND MACROPINOCYTOSIS IN BOVINE MONOCYTES |
Q39669824 | New developments in C5a receptor signaling |
Q91713267 | New insights into the immune functions of complement |
Q27022525 | Nucleic acids and endosomal pattern recognition: how to tell friend from foe? |
Q38991048 | Old dogs-new tricks: immunoregulatory properties of C3 and C5 cleavage fragments |
Q40706208 | PA-X-associated early alleviation of the acute lung injury contributes to the attenuation of a highly pathogenic H5N1 avian influenza virus in mice |
Q35544574 | Pathogenic microbes and community service through manipulation of innate immunity |
Q53475097 | Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival. |
Q24655246 | Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics? |
Q33349475 | Programming dendritic cells to induce T(H)2 and tolerogenic responses |
Q39435029 | Redundant and regulatory roles for Toll-like receptors in Leishmania infection. |
Q35850677 | Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo |
Q34072846 | Role and mechanism of action of complement in regulating T cell immunity |
Q36022727 | Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis |
Q91583164 | Role of the complement system in the tumor microenvironment |
Q38248596 | Sepsis and immune response. |
Q37299969 | Signaling networks in Leishmania macrophages deciphered through integrated systems biology: a mathematical modeling approach |
Q47666318 | Species-specific differences in regulation of macrophage inflammation by the C3a-C3a receptor axis. |
Q34166226 | Sphingosine kinase 1 mediation of expression of the anaphylatoxin receptor C5L2 dampens the inflammatory response to endotoxin |
Q37113561 | Subversion of innate immunity by periodontopathic bacteria via exploitation of complement receptor-3 |
Q37634416 | Synergistic interaction between C5a and NOD2 signaling in the regulation of chemokine expression in RAW 264.7 macrophages |
Q36684909 | T-cell regulation: with complements from innate immunity |
Q24630948 | TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2 |
Q52370705 | Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues. |
Q49898514 | Targeting complement-mediated immunoregulation for cancer immunotherapy |
Q34969639 | The C5a anaphylatoxin receptor (C5aR1) protects against Listeria monocytogenes infection by inhibiting type 1 IFN expression |
Q36320011 | The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice |
Q24618908 | The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss |
Q34868949 | The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid |
Q41874105 | The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells. |
Q42152131 | The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease |
Q33912345 | The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. |
Q37226859 | The interaction between C5a and both C5aR and C5L2 receptors is required for production of G-CSF during acute inflammation |
Q36499763 | The role of complement in danger sensing and transmission |
Q34983578 | The role of the anaphylatoxins in health and disease |
Q51732392 | Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2. |
Q38004493 | Toll-like receptors in leishmania infections: guardians or promoters? |
Q36961063 | Transcriptional control of complement receptor gene expression |
Q47559046 | Treatment of Paraquat-Induced Lung Injury With an Anti-C5a Antibody: Potential Clinical Application |
Q33793485 | Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease |
Q83242114 | [Pathophysiological basis of surgery-linked sepsis] |
Q24336138 | gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway |
Search more.